MONOPTEROS
Live / Registered — Registered (as of 07 Jun 2022)
What this means for you
Registered since 07 Jun 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87827412
- Registration number
- 6754547
- Mark type
- Stylized text
- Filed
- 09 Mar 2018
- Published for opposition
- 26 Feb 2019
- Registered
- 07 Jun 2022
- Attorney of record
- Jenevieve Maerker, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for human use for treatment of oncological diseases and/or disorders; house mark for pharmaceutical preparations, namely, pharmaceuticals for treatment of oncological diseases and/or disorders
Owner
- Monopteros Therapeutics, Inc., Chestnut Hill, MA, US
- Monopteros Therapeutics, Inc., Chestnut Hill, MA, US
- Monopteros Therapeutics, Inc., Chestnut Hill, MA, US
Prosecution history
- 07 Jun 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 05 May 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 May 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 May 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Apr 2022 — USE AMENDMENT FILED
- 25 Apr 2022 — TEAS STATEMENT OF USE RECEIVED
- 20 Oct 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Oct 2021 — SOU EXTENSION 5 GRANTED
- 12 Oct 2021 — SOU EXTENSION 5 FILED
- 18 Oct 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Oct 2021 — SOU TEAS EXTENSION RECEIVED
- 14 Apr 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Apr 2021 — SOU EXTENSION 4 GRANTED
- 12 Apr 2021 — SOU EXTENSION 4 FILED